Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genital and sphincter disorders].

P A Joseph1, M de Sèze

  • 1Unités de Rééducation Neurologique, Service de Médecine Physique et de Réadaptation, CHU Pellegrin, 33076 Bordeaux. joseph@scico.u-bordeaux2.fr

Revue Neurologique
|January 15, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dropped head syndrome in severe hypotension.

Revue neurologique·2024
Same author

How neurourology has developed in France since 54 years: description of the "Groupe d'Etudes de Neurourologie de Langue Française" (G.E.N.U.L.F.) or the French Speaking Working Group on Neuro-Urology (FSWGNU).

World journal of urology·2023
Same author

[Guidelines on the urological management of the adult patient with spinal dysraphism (spina bifida)].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Intermittent catheterization: Clinical practice guidelines from Association Française d'Urologie (AFU), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP).

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same author

[Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2018
Same author

Construction and feasibility study of the SOFMER Activity Score (SAS), a new assessment of physical and cognitive activity.

Annals of physical and rehabilitation medicine·2018
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Most multiple sclerosis (MS) patients experience bladder dysfunction, primarily overactive bladder. Effective management involves understanding bladder emptying and utilizing treatments like anticholinergics or intermittent self-catheterization.

Area of Science:

  • Neurology
  • Urology

Context:

  • Multiple sclerosis (MS) frequently causes symptomatic bladder dysfunction.
  • Key issues include detrusor hypereflexia and sphincter dyssynergia, impacting bladder control.

Purpose:

  • To review current and emerging treatments for bladder dysfunction in MS patients.
  • To highlight the importance of assessing bladder emptying in patients with overactive bladder symptoms.

Summary:

  • Anticholinergic medications are standard for overactive bladder in MS. Other options include desmopressin, surgery, and catheters.
  • Intravesical capsaicin and botulinum toxin show promise for refractory hyperreflexia.
  • Intermittent self-catheterization is crucial for managing incomplete emptying, with alternatives for those with physical or cognitive limitations.

Related Experiment Videos

  • Treatments for sexual dysfunction and anorectal issues in MS are also discussed, including sildenafil for erectile dysfunction and therapies for dyspareunia.

    • Impact:

    • Provides a comprehensive overview of bladder management strategies for MS patients.
    • Informs clinicians on diverse treatment options, from medication to surgical interventions.
    • Emphasizes a patient-centered approach considering physical, cognitive, and motivational factors.